← Back to Events
MANUFACTURING CONCLUDED
Advanced Therapies Week
One of the most prominent CGT and regenerative medicine conferences, bringing together biotechnology, pharmaceutical, CDMO, and investment communities to discuss scientific development, scale-up, commercialization, and investment.[5]
1,000+ Attendees
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
🇺🇸 Latest Americas News
All news → May 5 Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas May 5 Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment May 5 CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD May 5 Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD